Holen Sie sich die Stockscreener-App
39.62
0.70%
-0.28
Handel nachbörslich:
39.62
Schlusskurs vom Vortag:
$39.90
Offen:
$39.73
24-Stunden-Volumen:
545.34K
Relative Volume:
0.91
Marktkapitalisierung:
$2.15B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$23.68M
KGV:
94.33
EPS:
0.42
Netto-Cashflow:
$108.67M
1W Leistung:
-2.00%
1M Leistung:
-3.20%
6M Leistung:
-24.56%
1J Leistung:
-29.09%
1-Tages-Spanne:
$39.39
$40.30
1-Wochen-Bereich:
$39.16
$40.89
52-Wochen-Spanne:
$36.85
$64.47
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
39.62 | 2.15B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
131.35 | 227.80B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.80 | 149.09B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
367.54 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.98 | 114.12B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.19 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova to Announce First-Quarter 2025 Results - Business Wire
LivaNova (NASDAQ:LIVN) investors are sitting on a loss of 50% if they invested three years ago - Yahoo Finance
Should You Think About Buying LivaNova PLC (NASDAQ:LIVN) Now? - Simply Wall St
LivaNova PLC (LIVN) Shares Up 0.4% on Mar 19 - GuruFocus.com
Vagus Nerve Stimulators Market is Expected to Witness Positive - openPR
Jefferies cuts Livanova stock price target to $74 from $80 - Investing.com India
Barclays maintains Livanova stock with $56 target, cites clarity By Investing.com - Investing.com South Africa
Jefferies cuts Livanova stock price target to $74 from $80 By Investing.com - Investing.com Australia
LivaNova to record $363 million liability after court ruling By Investing.com - Investing.com Australia
Needham maintains Livanova buy rating, $64 target amid liability By Investing.com - Investing.com Australia
Barclays Maintains Livanova (LIVN) at Equalweight - StreetInsider.com
Barclays Starts Livanova (LIVN) at Equalweight - StreetInsider.com
Needham maintains Livanova buy rating, $64 target amid liability - Investing.com
LivaNova to record $363 million liability after court ruling - Investing.com
LivaNova Faces €333 Million Liability Ruling - TipRanks
Supreme Court Rules LivaNova Not Liable For 157 Mln Euros Payments In Environmental Liabilities Case - Marketscreener.com
LivaNova PLC (NASDAQ:LIVN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
LivaNova’s SWOT analysis: medical tech firm’s stock faces growth and legal hurdles - Investing.com Australia
Cardiovascular Devices Market Booming with Technological - openPR
Autotransfusion Devices and Consumables Market is Estimated - openPR
LivaNova’s SWOT analysis: medical tech firm’s stock faces growth and legal hurdles By Investing.com - Investing.com South Africa
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Bank of New York Mellon Corp - Defense World
Vagus Nerve Stimulators Market Generated Opportunities, - openPR
LivaNova at Barclays Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
LivaNova at Barclays Conference: Strategic Growth and Innovation - Investing.com India
When the Price of (LIVN) Talks, People Listen - Stock Traders Daily
Goldman Sachs maintains Livanova buy rating, $55 target By Investing.com - Investing.com UK
Barclays Cuts LivaNova (NASDAQ:LIVN) Price Target to $56.00 - Defense World
Mutual of America Capital Management LLC Sells 663 Shares of LivaNova PLC (NASDAQ:LIVN) - Defense World
Livanova PLC to Host Earnings Call - ACCESS Newswire
LivaNova stock hits 52-week low at $40.36 amid market challenges - Investing.com Australia
LivaNova stock hits 52-week low at $40.36 amid market challenges By Investing.com - Investing.com South Africa
Medical Implants Market Set to Witness Significant Growth by 2025-2032: Biotronik, Inc., Livanova Plc, - EIN News
LivaNova's (NASDAQ:LIVN) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Latin America Vagus Nerve Stimulation Market Report, 2030 - Grand View Research
Is LivaNova PLC (LIVN) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
After M&A Boondoggles, Livanova Refocuses on Core Businesses - Morningstar
LivaNova (NASDAQ:LIVN) Given New $55.00 Price Target at The Goldman Sachs Group - Defense World
Cardiac Surgery Devices Market Size, Share, Industry Trends, - openPR
LivaNova PLC (NASDAQ:LIVN) Stock Holdings Boosted by Principal Financial Group Inc. - Defense World
LivaNova (NASDAQ:LIVN) Given New $60.00 Price Target at Mizuho - MarketBeat
Needham & Company LLC Has Lowered Expectations for LivaNova (NASDAQ:LIVN) Stock Price - MarketBeat
LivaNova (NASDAQ:LIVN) Issues FY 2025 Earnings Guidance - MarketBeat
LivaNova (NASDAQ:LIVN) Cut to “Peer Perform” at Wolfe Research - Defense World
LivaNova (NASDAQ:LIVN) Hits New 12-Month LowTime to Sell? - MarketBeat
7 Best Medical Technology Stocks To Buy According To Analysts - Insider Monkey
Stifel Nicolaus Lowers LivaNova (NASDAQ:LIVN) Price Target to $60.00 - MarketBeat
LivaNova (NASDAQ:LIVN) Issues FY25 Earnings Guidance - MarketBeat
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by Wolfe Research - MarketBeat
How To Trade (LIVN) - Stock Traders Daily
Decoding LivaNova PLC (LIVN): A Strategic SWOT Insight - GuruFocus.com
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
3.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):